Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma
Public ClinicalTrials.gov record NCT01239875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
LS1081, "A Pilot Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation or Intradermally for Patients With B-Cell Non-Hodgkin's Lymphoma"
Study identification
- NCT ID
- NCT01239875
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Early Phase 1
- Lead sponsor
- Mayo Clinic
- Other
- Enrollment
- 16 participants
Conditions and interventions
Conditions
- Adult Diffuse Mixed Cell Lymphoma
- Adult Diffuse Small Cleaved Cell Lymphoma
- Adult Grade III Lymphomatoid Granulomatosis
- Adult Immunoblastic Large Cell Lymphoma
- Adult Lymphoblastic Lymphoma
- Cutaneous B-cell Non-Hodgkin Lymphoma
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- Grade 1 Follicular Lymphoma
- Grade 2 Follicular Lymphoma
- Grade 3 Follicular Lymphoma
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
- Nodal Marginal Zone B-cell Lymphoma
- Small Lymphocytic Lymphoma
- Splenic Marginal Zone Lymphoma
- Waldenstrom Macroglobulinemia With Nodal Disease
Interventions
- autologous dendritic cell-tumor fusion vaccine Biological
- cryotherapy Procedure
- dendritic cell vaccine therapy Biological
- immunoenzyme technique Other
- immunohistochemistry staining method Other
- laboratory biomarker analysis Other
- pneumococcal polyvalent vaccine Biological
Biological · Procedure · Other
Eligibility (public fields only)
- Age range
- 18 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2010
- Primary completion
- Nov 23, 2015
- Completion
- Jul 16, 2019
- Last update posted
- Jan 13, 2020
2010 – 2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01239875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2020 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01239875 live on ClinicalTrials.gov.